相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial
B. G. Wortman et al.
GYNECOLOGIC ONCOLOGY (2018)
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
S. M. de Boer et al.
ANNALS OF ONCOLOGY (2018)
A Phase 3 Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-Risk, Early-Stage Endometrial Cancer: A Gynecology Oncology Group Study
M. Randall et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
Louis J. M. van der Putten et al.
BRITISH JOURNAL OF CANCER (2016)
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts
Ellen Stelloo et al.
CLINICAL CANCER RESEARCH (2016)
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
Inge C. Van Gool et al.
MODERN PATHOLOGY (2016)
A clinically applicable molecular-based classification for endometrial cancers
A. Talhouk et al.
BRITISH JOURNAL OF CANCER (2015)
Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer - A pooled analysis of PORTEC 1 and 2 trials
Tjalling Bosse et al.
EUROPEAN JOURNAL OF CANCER (2015)
Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial
Stephanie M. de Boer et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
David N. Church et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
T. Bosse et al.
EUROPEAN JOURNAL OF CANCER (2014)
L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
Alain G. Zeimet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
EXTERNAL PELVIC AND VAGINAL IRRADIATION VERSUS VAGINAL IRRADIATION ALONE AS POSTOPERATIVE THERAPY IN MEDIUM-RISK ENDOMETRIAL CARCINOMA-A PROSPECTIVE RANDOMIZED STUDY
Bengt Sorbe et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
FIFTEEN-YEAR RADIOTHERAPY OUTCOMES OF THE RANDOMIZED PORTEC-1 TRIAL FOR ENDOMETRIAL CARCINOMA
Carien L. Creutzberg et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
A Role for Adjuvant Radiation in Clinically Early Carcinoma of the Endometrium?
Gillian Monica Thomas
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
R. A. Nout et al.
LANCET (2010)
Quality of Life After Pelvic Radiotherapy or Vaginal Brachytherapy for Endometrial Cancer: First Results of the Randomized PORTEC-2 Trial
Remi A. Nout et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results,, systematic review, and meta-analysis
P. Blake et al.
LANCET (2009)
Lymphadenectomy in endometrial cancer Reply
Henry Kitchener et al.
LANCET (2009)
Mandatory second opinion in surgical pathology referral material: Clinical consequences of major disagreements
Elizabeth Manion et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study
Nobuyuki Susumu et al.
GYNECOLOGIC ONCOLOGY (2008)
Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial
Pierluigi Benedetti Panici et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial
R. Maggi et al.
BRITISH JOURNAL OF CANCER (2006)
Lymphvascular space involvement:: an independent prognostic factor in endometrial cancer
JM Briët et al.
GYNECOLOGIC ONCOLOGY (2005)
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
HM Keys et al.
GYNECOLOGIC ONCOLOGY (2004)
Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma
AN Scholten et al.
CANCER (2004)
Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?
DE Cohn et al.
GYNECOLOGIC ONCOLOGY (2002)
Long-term outcome in endometrial carcinoma favors a two- instead of a three-tiered grading system
AN Scholten et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma:: multicentre randomised trial
CL Creutzberg et al.
LANCET (2000)
分享论文
